Clinical and Surgical Sciences, University of Edinburgh, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, United Kingdom.
Clinical and Surgical Sciences, University of Edinburgh, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, United Kingdom.
Clin Nutr. 2019 Dec;38(6):2875-2880. doi: 10.1016/j.clnu.2018.12.023. Epub 2018 Dec 24.
Following the consensus definition of cancer cachexia, more studies are using CT scan analysis of truncal muscles as a marker of muscle wasting. However, how CT-derived body composition relates to function, strength and power in patients with cancer is largely unknown.
We aimed to describe the relationship between CT truncal (L3) skeletal muscle index (SMI) and MRI quadriceps cross sectional area with lower limb strength, power and measures of complex function.
Patients undergoing assessment for potentially curative surgery for oesophagogastric or pancreatic cancer were recruited from the regional upper gastrointestinal (UGI) or hepatopancreaticobiliary (HPB) multi-disciplinary team meetings. Maximum Isometric Knee Extensor Strength (IKES) and Maximum Leg Extensor Power (Nottingham Power Rig) (LEP) were used as measures of lower limb performance. Both Sit to Stand (STS) and Timed Up and Go (TUG) were used as measures of global complex muscle function. Muscle SMI was measured from routine CT scans at the level of the third lumbar vertebrae (L3) and MRI scan was used for the assessment of quadriceps muscles. Linear regression analysis was performed for CT SMI or MRI quadriceps as a predictor of each measure of performance.
Forty-four patients underwent assessment. Height and weight were significantly related to function in terms of quadriceps power, while only weight was associated with strength (P < 0.001). CT SMI was not related to measures of quadriceps strength or power but had significant association with more complex functional measures (P = 0.006, R = 0.234 and 0.0019, R = 0.175 for STS and TUG respectively). In comparison, both gross and fat-subtracted measures of quadriceps muscle mass from MRI were significantly correlated with quadriceps strength and power (P < 0.001), but did not show any significant association with complex functional measures.
CT SMI and MRI quadriceps have been shown to reflect different aspects of functional ability with CT SMI being a marker of global muscle function and MRI quadriceps being specific to quadriceps power and strength. This should therefore be considered when choosing outcome measures for trials or definitions of muscle mass and function.
根据癌症恶病质的共识定义,越来越多的研究使用 CT 扫描分析躯干肌肉作为肌肉消耗的标志物。然而,在癌症患者中,CT 衍生的身体成分与功能、力量和功率的关系在很大程度上尚不清楚。
我们旨在描述 CT 躯干(L3)骨骼肌指数(SMI)与 MRI 股四头肌横截面积与下肢力量、功率和复杂功能测量之间的关系。
从区域上消化道(UGI)或肝胆胰腺多学科团队会议中招募接受潜在可治愈手术治疗食管胃或胰腺癌症评估的患者。最大等长膝关节伸展力量(IKES)和最大腿部伸展功率(诺丁汉功率钻机)(LEP)用作下肢性能的测量指标。坐立起身(STS)和起身行走测试(TUG)都用作整体复杂肌肉功能的测量指标。从第三腰椎(L3)水平的常规 CT 扫描测量肌肉 SMI,并使用 MRI 扫描评估股四头肌。线性回归分析用于 CT SMI 或 MRI 股四头肌作为每个性能测量指标的预测指标。
44 名患者接受了评估。身高和体重与股四头肌力量的功能显著相关,而只有体重与力量相关(P<0.001)。CT SMI 与股四头肌力量或功率的测量指标无关,但与更复杂的功能测量指标显著相关(P=0.006,R=0.234 和 0.0019,R=0.175 分别为 STS 和 TUG)。相比之下,MRI 测量的股四头肌的总体积和去脂量与股四头肌力量和功率均显著相关(P<0.001),但与复杂功能测量指标无显著相关性。
CT SMI 和 MRI 股四头肌均反映了功能能力的不同方面,CT SMI 是整体肌肉功能的标志物,MRI 股四头肌则是股四头肌力量和强度的特异性标志物。因此,在选择试验的结果测量指标或肌肉质量和功能的定义时,应考虑这一点。